Anti-Thrombotic Strategy to Lower All Cardiovascular and Neurologic Ischemic and Hemorrhagic Events After Trans-Aortic Valve Implantation for Aortic Stenosis
Phase of Trial: Phase III
Latest Information Update: 17 May 2017
At a glance
- Drugs Apixaban (Primary)
- Indications Acute coronary syndromes; Deep vein thrombosis; Pulmonary embolism; Stroke
- Focus Therapeutic Use
- Acronyms ATLANTIS
- 02 Feb 2017 Planned number of patients changed from 1509 to 1510.
- 02 Feb 2017 Planned End Date changed from 1 Sep 2018 to 2 Apr 2019.
- 02 Feb 2017 Planned primary completion date changed from 1 Sep 2018 to 2 Apr 2019.